Cargando…

A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus

BACKGROUND: A vaccine (HB-101) consisting of 2 nonreplicating lymphocytic choriomeningitis virus (LCMV) vectors expressing the human cytomegalovirus antigens glycoprotein B (gB) and the 65-kD phosphoprotein (pp65), respectively, is in development to prevent cytomegalovirus infection. METHODS: HB-101...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwendinger, Michael, Thiry, Georges, De Vos, Beatrice, Leroux-Roels, Geert, Bruhwyler, Jacques, Huygens, Ariane, Ganeff, Corinne, Buchinger, Heidemarie, Orlinger, Klaus K, Pinschewer, Daniel D, Monath, Thomas P, Lilja, Anders E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016443/ https://www.ncbi.nlm.nih.gov/pubmed/32313928 http://dx.doi.org/10.1093/infdis/jiaa121

Ejemplares similares

1531. A CMV Vaccine Based on Non-Replicating Lymphocytic Choriomeningitis Virus Vectors Expressing gB and pp65 Is Safe and Immunogenic in Healthy Volunteers, Allowing for Development of a Phase II Clinical Trial in Living Donor Kidney Transplant Recipients
por: Kotton, Camille Nelson, et al.
Publicado: (2018)

Double-Blind, Placebo-Controlled, Dose-Escalating Study Evaluating the Safety and Immunogenicity of an Epitope-Specific Chemically Defined Nanoparticle RSV Vaccine
por: Leroux-Roels, Isabel, et al.
Publicado: (2023)

Live-attenuated lymphocytic choriomeningitis virus-based vaccines for active immunotherapy of HPV16-positive cancer
por: Schmidt, Sarah, et al.
Publicado: (2020)

Immunity to Cytomegalovirus in Early Life
por: Huygens, Ariane, et al.
Publicado: (2014)

Characterization of host proteins interacting with the lymphocytic choriomeningitis virus L protein
por: Khamina, Kseniya, et al.
Publicado: (2017)

Lymphocytic Choriomeningitis in Michigan
por: Foster, Erik S., et al.
Publicado: (2006)

Randomized, Double-Blind, Reference-Controlled, Phase 2a Study Evaluating the Immunogenicity and Safety of OVX836, A Nucleoprotein-Based Influenza Vaccine
por: Leroux-Roels, Isabel, et al.
Publicado: (2022)

Association of Cytomegalovirus DNA and Immunologic Markers of Cardiovascular Disease
por: Garg, Ankita, et al.
Publicado: (2019)

A Prospective Study of Cytomegalovirus-Specific Cell-Mediated Immune Monitoring and Cytomegalovirus Infection in Patients With Active Systemic Lupus Erythematosus Receiving Immunosuppressants
por: Bruminhent, Jackrapong, et al.
Publicado: (2021)

Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza Disease
por: Benoit, Anne, et al.
Publicado: (2015)

In Utero Activation of Natural Killer Cells in Congenital Cytomegalovirus Infection
por: Vaaben, Anna V, et al.
Publicado: (2022)

LYMPHOCYTIC CHORIOMENINGITIS IN THE SYRIAN HAMSTER
por: Smadel, J. E., et al.
Publicado: (1942)

Infection with the Virus of Choriomeningitis in Man
por: Howard, Marion E.
Publicado: (1940)

Early Antimicrobial De-escalation and Stewardship in Adult Hematopoietic Stem Cell Transplantation Recipients: Retrospective Review
por: Snyder, Matthew, et al.
Publicado: (2017)

Implementation of a Rapid Multiplex Polymerase Chain Reaction Pneumonia Panel and Subsequent Antibiotic De-escalation
por: Miller, Molly M, et al.
Publicado: (2023)

The Excess Burden of Cytomegalovirus in African American Communities: A Geospatial Analysis
por: Lantos, Paul M., et al.
Publicado: (2015)

Emergence and Persistence of Letermovir-Resistant Cytomegalovirus in a Patient With Primary Immunodeficiency
por: Popping, Stephanie, et al.
Publicado: (2019)

A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine
por: Leroux-Roels, Isabel, et al.
Publicado: (2022)

P19-37. Replication-defective lymphocytic choriomeningitis virus vectors boost cellular and humoral immunity after DNA or adenovirus vector priming
por: Flatz, LR, et al.
Publicado: (2009)

Human Cytomegalovirus Up-Regulates Endothelin Receptor Type B: Implication for Vasculopathies?
por: Yaiw, Koon-Chu, et al.
Publicado: (2015)

Molecular and Culture-Based Bronchoalveolar Lavage Fluid Testing for the Diagnosis of Cytomegalovirus Pneumonitis
por: Tan, Susanna K., et al.
Publicado: (2016)

Cardiac Microvascular Dysfunction in Women Living With HIV Is Associated With Cytomegalovirus Immunoglobulin G
por: Knudsen, Andreas, et al.
Publicado: (2018)

Cytomegalovirus Latent Infection is Associated with an Increased Risk of COVID-19-Related Hospitalization
por: Alanio, Cécile, et al.
Publicado: (2022)

Outcomes of Cytomegalovirus Viremia Treatment in Critically Ill Patients With COVID-19 Infection
por: Schoninger, Scott, et al.
Publicado: (2022)

Cytomegalovirus Viremia Predicts Postdischarge Mortality in Kenyan HIV-Exposed Uninfected Children( )
por: Pavlinac, Patricia B, et al.
Publicado: (2022)

Safety and Immunogenicity of Different Formulations of Norovirus Vaccine Candidate in Healthy Adults: A Randomized, Controlled, Double-Blind Clinical Trial
por: Leroux-Roels, Geert, et al.
Publicado: (2018)

Replication-Deficient Lymphocytic Choriomeningitis Virus-Vectored Vaccine Candidate for the Induction of T Cell Immunity against Mycobacterium tuberculosis
por: Belnoue, Elodie, et al.
Publicado: (2022)

Assessment of Antibiotic De-escalation by Spectrum Score in Patients With Nosocomial Pneumonia: A Single-Center, Retrospective Cohort Study
por: Ilges, Dan, et al.
Publicado: (2021)

PATHOGENESIS OF CHRONIC DISEASE ASSOCIATED WITH PERSISTENT LYMPHOCYTIC CHORIOMENINGITIS VIRAL INFECTION : II. RELATIONSHIP OF THE ANTI-LYMPHOCYTIC CHORIOMENINGITIS IMMUNE RESPONSE TO TISSUE INJURY IN CHRONIC LYMPHOCYTIC CHORIOMENINGITIS DISEASE
por: Oldstone, Michael B. A., et al.
Publicado: (1970)

Safety and Efficacy of Antibiotic De-escalation and Discontinuation in High-Risk Hematological Patients With Febrile Neutropenia: A Single-Center Experience
por: Verlinden, Anke, et al.
Publicado: (2021)

THE INACTIVATION OF THE VIRUS OF LYMPHOCYTIC CHORIOMENINGITIS BY SOAPS
por: Stock, C. Chester, et al.
Publicado: (1943)

THE EPIDEMIOLOGY OF LYMPHOCYTIC CHORIOMENINGITIS IN WHITE MICE
por: Traub, Erich
Publicado: (1936)

Human Infection with Lymphocytic Choriomeningitis Virus
por: Barton, Leslie L.
Publicado: (2010)

Microcephaly Caused by Lymphocytic Choriomeningitis Virus
por: Delaine, Maia, et al.
Publicado: (2017)

Lymphocytic Choriomeningitis Virus Infection, Australia
por: Caly, Leon, et al.
Publicado: (2022)

Reemergence of Lymphocytic Choriomeningitis Mammarenavirus, Germany
por: Mehl, Calvin, et al.
Publicado: (2023)

Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial
por: Leroux-Roels, Isabel, et al.
Publicado: (2022)

Cytomegalovirus Retinitis Screening and Treatment in Human Immunodeficiency Virus Patients in Malawi: A Feasibility Study
por: Ocieczek, Paulina, et al.
Publicado: (2019)

Are the Patterns of Cytomegalovirus Viral Load Seen After Solid Organ Transplantation Affected by Circadian Rhythm?
por: Rafferty, Hannah, et al.
Publicado: (2022)

Drug Resistance Mutations and Associated Phenotypes Detected in Clinical Trials of Maribavir for Treatment of Cytomegalovirus Infection
por: Chou, Sunwen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5bfujro8vpa23afqah9h0avdpk